Kris Kowdley, M.D., also named research director of the Swedish Organ Care Program
SEATTLE — Sept. 25, 2014
—Internationally renowned physician and researcher Kris V. Kowdley, M.D., FACP, FACG, AGAF and AASLD Fellow has joined the Swedish Liver Center’s medical staff as Director of the Swedish Liver Care Network and Research Director of the Organ Care Program. Dr. Kowdley will provide transplant and liver care for patients while continuing his groundbreaking research into Hepatitis C. Dr. Kowdley’s first day at Swedish was Sept. 15.
“We are delighted to welcome Dr. Kowdley to the Swedish Liver Center medical staff,” said Marquis Hart, M.D., director of the Swedish Organ Transplant Program. “Dr. Kowdley’s ambitious research is giving hope to patients with serious liver disease and we are excited to extend his care to our patients.”
Prior to Swedish, Dr. Kowdley served as the director of the Liver Center of Excellence and the director of research at the Digestive Disease Institute at Virginia Mason Medical Center in Seattle.
Dr. Kowdley has presented his research on liver diseases at more than 125 national and international medical centers and scientific symposia. He is the author of more than 350 articles, book chapters, reviews and commentaries. He has been published in the New England Journal of Medicine (NEJM)
, Annals of Internal Medicine
and the American Journal of Physiology.
Dr. Kowdley is first author of two seminal papers this year in the NEJM
of novel therapies with a high rate of cure for chronic hepatitis C. The AVIATOR trial is the first large study of all-oral treatment for hepatitis C. More than 95 percent of AVIATOR study patients achieved a cure with the 3-D and ribavirin regimen. The second study, known as ION-3, showed that a fixed-dose combination tablet of once-daily ledipasvir and sofosbuvir for eight weeks achieved a cure in 94 percent of patients.